ISSN 2639-9431
Vol. 9, Issue 2, 2026May 12, 2026 EDT
Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive Engineering
Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive Engineering
Articles in Vol. 9, Issue 2, 2026
Vol. 9, Issue 2, 2026
- Nanoemulsion-Enhanced Cardiac Delivery of Omega-3 Fatty Acids Reduces Myocardial Fibrosis and Improves Diastolic Function in a Murine HFpEF ModelKati FridYair RokachOrli BinyaminTsipora Markovitz-PatcherAlicia I. Leikin-FrenkelLiraz LarushShlomo MagdassiRabea AslehRuth Gabizon
- Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive EngineeringPanijapatr Wasubhadtanasaka
- Nanomaterial-Based Immunosensors: Conjugation Strategies and Biomedical Applications of 0D NanosensorsMelika SanavandiKimia AalikhaniAhmad FazilatEhsan HasanzadehMohammad ValiloBabak Shokri
1.
Wasubhadtanasaka P. Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive Engineering. Precis Nanomed. 2026;9(2):1815-1833. doi:10.33218/001c.161262